The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2025, according to Statista. A large portion of that figure is from the oncology segment, which is expected to generate $208 billion in sales next year. Longer-term sales projections show the industry should grow 4.7% annually, reaching $1.45 trillion by 2029.
Not only are pharmaceutical stocks excellent defensive investments in an uncertain economy, but some pharma stocks also pay sizable dividends that can be a source of steady income and help offset the impact of inflation. Here are seven pharmaceutical stocks to buy with dividends of at least 2%, according to Argus.
This post originally appeared at U.S. News & World Report.